BRC
TMO icon

Bell Rock Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bell Rock Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-502
Closed -$163K – 280
2019
Q4 		$163K Buy
502
+100
+25% +$30.3K 0.14% 123
2019
Q3 		$118K Sell
402
-14
-3% -$4.01K 0.1% 139
2019
Q2 		$121K Sell
416
-6,516
-94% -$1.79M 0.11% 143
2019
Q1 		$1.9M Sell
6,932
-25
-0.4% -$6.22K 1.09% 23
2018
Q4 		$1.56M Sell
6,957
-1,398
-17% -$328K 1.04% 28
2018
Q3 		$2.04M Buy
8,355
+51
+0.6% +$11.7K 1% 29
2018
Q2 		$1.72M Buy
8,304
+102
+1% +$21.7K 0.87% 36
2018
Q1 		$1.69M Buy
8,202
+2,121
+35% +$445K 0.9% 36
2017
Q4 		$1.15M Buy
6,081
+781
+15% +$150K 0.62% 46
2017
Q3 		$1M Buy
5,300
+2,910
+122% +$527K 0.57% 54
2017
Q2 		$417K Sell
2,390
-3,075
-56% -$517K 0.26% 78
2017
Q1 		$839K Buy
+5,465
New +$835K 0.78% 30

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bell Rock Capital's TMO Position: Q1 2020 in Review

Bell Rock Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 502 shares — an estimated $163K sold.

Bell Rock Capital first reported a position in TMO in Q1 2017 and held it in 12 quarters. The position peaked at $2.04M in Q3 2018. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

  • Bell Rock Capital reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
  • Bell Rock Capital sold 502 Thermo Fisher Scientific shares in Q1 2020, an estimated $163K.
  • Bell Rock Capital first reported a position in Thermo Fisher Scientific in Q1 2017 and held it in 12 quarters.
  • Bell Rock Capital's Thermo Fisher Scientific position peaked at $2.04M in Q3 2018.
  • 1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.